In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Chiron gets DepoTech's DepoCyt cancer therapeutic

Executive Summary

Chiron acquired exclusive US, Canadian, and European rights to DepoTech's DepoCyt, a tumor therapeutic currently in Phase III for neoplastic meningitis, and will apply Depotech's DepoFoam delivery technology to its own compounds.
Deal Industry
  • Biotechnology
    • Liposomes
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • R+D and Marketing-Licensing
    • Includes Equity

Related Companies

Advertisement
UsernamePublicRestriction

Register